- €18.28bn
- €14.31bn
- €22.26bn
- 79
- 73
- 68
- 88
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 23,315 | 21,852 | 22,202 | 24,911 | 22,258 |
Cost of Revenue | |||||
Gross Profit | 8,326 | 8,193 | 8,834 | 10,222 | 8,687 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 22,830 | 20,967 | 20,044 | 22,593 | 20,570 |
Operating Profit | 485 | 885 | 2,158 | 2,318 | 1,688 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 156 | 743 | 1,926 | 2,184 | 1,499 |
Provision for Income Taxes | |||||
Net Income After Taxes | 18 | -2,513 | 1,654 | 4,210 | 674 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 7 | -2,523 | 1,623 | 4,250 | 665 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 7 | -2,523 | 1,623 | 4,250 | 665 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.137 | -0.331 | 0.307 | 0.791 | 0.133 |
Dividends per Share |